Stay updated on Eteplirsen Safety in Early Duchenne Clinical Trial
Sign up to get notified when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.

Latest updates to the Eteplirsen Safety in Early Duchenne Clinical Trial page
- CheckyesterdayChange DetectedNew help/navigation sections have been added to the study record page, including How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment header formatting was updated and the revision label changed from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check8 days agoChange DetectedThe page now displays Revision: v3.5.5, indicating a minor platform update. No study information appears to have changed.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check30 days agoChange DetectedA new Revision: v3.5.4 appears, replacing the previous Revision: v3.5.3. This indicates a backend or documentation update to the page rather than changes to study data or content.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision: v3.5.3 replaces the previous v3.5.2, indicating a new release of the ClinicalTrials.gov platform.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3.SummaryDifference0.1%

Stay in the know with updates to Eteplirsen Safety in Early Duchenne Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Eteplirsen Safety in Early Duchenne Clinical Trial page.